144,429 members

Skip to content. | Skip to navigation

News

New lung cancer treatment option approved by NICE

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

New lung cancer treatment option approved by NICE

Another new life-extending treatment for some people with lung cancer is to be made available on the cancer drugs fund following its approval by NICE in draft guidance.

Immunotherapy drug pembrolizumab (also known as Keytruda) used with chemotherapy drugs carboplatin and paclitaxel will now be an option for adults with squamous non-small-cell lung cancer (NSCLC) which has spread to other parts of the body and who haven’t had any previous treatments. More....